BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

529 related articles for article (PubMed ID: 37619252)

  • 1. Hormone therapy for sexual function in perimenopausal and postmenopausal women.
    Lara LA; Cartagena-Ramos D; Figueiredo JB; Rosa-E-Silva ACJ; Ferriani RA; Martins WP; Fuentealba-Torres M
    Cochrane Database Syst Rev; 2023 Aug; 8(8):CD009672. PubMed ID: 37619252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hormone therapy for sexual function in perimenopausal and postmenopausal women.
    Nastri CO; Lara LA; Ferriani RA; Rosa-E-Silva AC; Figueiredo JB; Martins WP
    Cochrane Database Syst Rev; 2013 Jun; (6):CD009672. PubMed ID: 23737033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dehydroepiandrosterone for women in the peri- or postmenopausal phase.
    Scheffers CS; Armstrong S; Cantineau AE; Farquhar C; Jordan V
    Cochrane Database Syst Rev; 2015 Jan; 1(1):CD011066. PubMed ID: 25879093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-term and long-term effects of tibolone in postmenopausal women.
    Formoso G; Perrone E; Maltoni S; Balduzzi S; Wilkinson J; Basevi V; Marata AM; Magrini N; D'Amico R; Bassi C; Maestri E
    Cochrane Database Syst Rev; 2016 Oct; 10(10):CD008536. PubMed ID: 27733017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term hormone therapy for perimenopausal and postmenopausal women.
    Marjoribanks J; Farquhar C; Roberts H; Lethaby A; Lee J
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD004143. PubMed ID: 28093732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Black cohosh (Cimicifuga spp.) for menopausal symptoms.
    Leach MJ; Moore V
    Cochrane Database Syst Rev; 2012 Sep; 2012(9):CD007244. PubMed ID: 22972105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pre-operative endometrial thinning agents before endometrial destruction for heavy menstrual bleeding.
    Tan YH; Lethaby A
    Cochrane Database Syst Rev; 2013 Nov; (11):CD010241. PubMed ID: 24234875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioidentical hormones for women with vasomotor symptoms.
    Gaudard AM; Silva de Souza S; Puga ME; Marjoribanks J; da Silva EM; Torloni MR
    Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD010407. PubMed ID: 27479272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormone therapy for sexual function in perimenopausal and postmenopausal women: a systematic review and meta-analysis update.
    Meziou N; Scholfield C; Taylor CA; Armstrong HL
    Menopause; 2023 Jun; 30(6):659-671. PubMed ID: 37159867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long term hormone therapy for perimenopausal and postmenopausal women.
    Marjoribanks J; Farquhar C; Roberts H; Lethaby A
    Cochrane Database Syst Rev; 2012 Jul; (7):CD004143. PubMed ID: 22786488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective oestrogen receptor modulators (SERMs) for endometriosis.
    van Hoesel MH; Chen YL; Zheng A; Wan Q; Mourad SM
    Cochrane Database Syst Rev; 2021 May; 5(5):CD011169. PubMed ID: 33973648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Add-back therapy with GnRH analogues for uterine fibroids.
    Moroni RM; Martins WP; Ferriani RA; Vieira CS; Nastri CO; Candido Dos Reis FJ; Brito LG
    Cochrane Database Syst Rev; 2015 Mar; 2015(3):CD010854. PubMed ID: 25793972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gonadotropin-releasing hormone analogues for endometriosis.
    Veth VB; van de Kar MM; Duffy JM; van Wely M; Mijatovic V; Maas JW
    Cochrane Database Syst Rev; 2023 Jun; 6(6):CD014788. PubMed ID: 37341141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acupuncture for menopausal hot flushes.
    Dodin S; Blanchet C; Marc I; Ernst E; Wu T; Vaillancourt C; Paquette J; Maunsell E
    Cochrane Database Syst Rev; 2013 Jul; 2013(7):CD007410. PubMed ID: 23897589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective progesterone receptor modulators (SPRMs) for uterine fibroids.
    Murji A; Whitaker L; Chow TL; Sobel ML
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD010770. PubMed ID: 28444736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exercise for vasomotor menopausal symptoms.
    Daley A; Stokes-Lampard H; Thomas A; MacArthur C
    Cochrane Database Syst Rev; 2014 Nov; 2014(11):CD006108. PubMed ID: 25431132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local oestrogen for vaginal atrophy in postmenopausal women.
    Lethaby A; Ayeleke RO; Roberts H
    Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD001500. PubMed ID: 27577677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endometrial preparation for women undergoing embryo transfer with frozen embryos or embryos derived from donor oocytes.
    Glujovsky D; Pesce R; Sueldo C; Quinteiro Retamar AM; Hart RJ; Ciapponi A
    Cochrane Database Syst Rev; 2020 Oct; 10(10):CD006359. PubMed ID: 33112418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relaxation for perimenopausal and postmenopausal symptoms.
    Saensak S; Vutyavanich T; Somboonporn W; Srisurapanont M
    Cochrane Database Syst Rev; 2014 Jul; (7):CD008582. PubMed ID: 25039019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.